Literature DB >> 11012233

Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.

.   

Abstract

In 1999, 360,076 cases of gonorrhea were reported in the United States (1). Gonorrhea is a major cause of pelvic inflammatory disease, often leading to ectopic pregnancy and infertility, and it can facilitate human immunodeficiency virus (HIV) transmission (2). During the 1980s, resistance to penicillin and tetracycline among gonococcal isolates became widespread; as a result, CDC recommended that other antimicrobial agents be used to treat gonorrhea. This report summarizes investigations of an increase in fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii and of a cluster of N. gonorrhoeae infections with decreased susceptibility to azithromycin in Missouri.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012233

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  15 in total

1.  Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.

Authors:  Shelly Sarwal; Tom Wong; Cathy Sevigny; Lai-King Ng
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

2.  Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.

Authors:  Sheldon R Morris; Douglas F Moore; Paul B Hannah; Susan A Wang; Julia Wolfe; David L Trees; Gail Bolan; Heidi M Bauer
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

3.  Here Comes the SSuN: Early Experiences with the STD Surveillance Network.

Authors:  Cornelis A Rietmeijer; Jennifer Donnelly; Kyle T Bernstein; Jennifer M Bissette; Summer Martins; Preeti Pathela; Julia A Schillinger; Mark R Stenger; Hillard Weinstock; Lori M Newman
Journal:  Public Health Rep       Date:  2009       Impact factor: 2.792

4.  Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.

Authors:  Motiur Rahman; Zafar Sultan; Shirajum Monira; Ashraful Alam; Khairun Nessa; Sonia Islam; Shamsun Nahar; Shahnewaz Alam Khan; Jozef Bogaerts; Nazrul Islam; John Albert
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 5.  Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Ann N Y Acad Sci       Date:  2011-08       Impact factor: 5.691

Review 6.  Drug treatment of nonviral sexually transmitted diseases: specific issues in adolescents.

Authors:  C E Lehmann; F M Biro
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

7.  Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples.

Authors:  Mark J Siedner; Mark Pandori; Lina Castro; Pennan Barry; William L H Whittington; Sally Liska; Jeffrey D Klausner
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

8.  Update on Quinolone Resistance in Neisseria gonorrhoeae.

Authors:  Jonathan M. Zenilman
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

9.  Examining Fluoroquinolone Claims Among Gonorrhea-Associated Prescription Drug Claims, 2000-2010.

Authors:  Kwame Owusu-Edusei; Danya S Carroll; Thomas L Gift
Journal:  Am J Prev Med       Date:  2015-07-16       Impact factor: 5.043

10.  Identification and analysis of amino acid mutations in porin IB that mediate intermediate-level resistance to penicillin and tetracycline in Neisseria gonorrhoeae.

Authors:  Melanie Olesky; Marcia Hobbs; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.